治疗I-III阶段状细胞门癌:一个比较有效性的系统审查
Alexander Troester1, Romil Parikh2, Bronwyn Southwell3
1Department of Surgery, University of Minnesota, Minneapolis, MN, USA.
Journal of the National Cancer Institute
|August 20, 2024
概括
用5-甲 (5-FU) 和米托米辛C进行化学辐射疗法 (CRT) 可以改善门癌的生存率,但会增加急性毒性. 添加帕克利塔塞尔可能会进一步提高疗效和毒性.
科学领域:
- 在瘤学瘤学.
- 临床研究 临床研究
- 癌症治疗方法 癌症治疗方法
背景情况:
- 状细胞门癌 (SCAC) 是一个重大的临床挑战.
- 有效的初始治疗策略对于I-III阶段的SCAC至关重要.
研究的目的:
- 评估SCAC的各种初始治疗策略的比较有效性和危害.
- 综合来自随机对照试验和非随机研究的证据.
主要方法:
- 在 MEDLINE,Embase 和 Cochrane 中央注册 (2000-2024) 的系统文献搜索.
- 包括随机对照试验和非随机干预研究.
- 使用标准化方法进行偏见风险评估和证据强度评估.
主要成果:
- 用5-甲 (5-FU) 和米托米辛C进行化学辐射治疗 (CRT) 可能会改善局部控制和单独辐射的存活率,并增加急性毒性.
- 与5-FU/mitomycin C一起的CRT可能在生存结果方面优于单独的5-FU.
- 将帕克利塔塞尔添加到基于capecitabine的CRT可能会提高存活率,但也会增加急性伤害.
结论:
- 治疗CRT疗法,特别是5-FU/mitomycin C或5-FU/cisplatin疗法,比单独照射或单剂CRT疗法更有效,但与更高的急性毒性有关.
- 组合化疗方案显示了提高疗效的潜力.
- 需要对监测和患者报告的结果进行进一步的研究.
更多相关视频
12:45Robot-assisted Total Mesorectal Excision and Lateral Pelvic Lymph Node Dissection for Locally Advanced Middle-low Rectal Cancer
Published on: February 12, 2022
5.6K
06:11Therapy Testing in a Spheroid-based 3D Cell Culture Model for Head and Neck Squamous Cell Carcinoma
Published on: April 20, 2018
9.8K
相关概念视频
Cancer Survival Analysis
334
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
334
Comparing the Survival Analysis of Two or More Groups
164
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
164
Cancer Therapies
7.6K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.6K
Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
